Comparison of Toric IOL Implantation and Opposite Clear Corneal Incision During Cataract Surgery to Correct Corneal Astigmatism

Sponsor
Vienna Institute for Research in Ocular Surgery (Other)
Overall Status
Completed
CT.gov ID
NCT01763151
Collaborator
(none)
55
1
2
27
2

Study Details

Study Description

Brief Summary

With increasing demands of patients concerning refractive outcome after cataract surgery, toric intraocular lenses (IOLs) that correct corneal astigmatism have been introduced more widely to cataract surgery. Originally toric IOLs were used mainly for patients with high degrees of astigmatism, especially after corneal surgical procedures such as penetrating keratoplasty. Since a couple of years, toric IOLs are available from numerous manufacturers to correct lower amounts of astigmatism which are much more prevalent with about 30% having a corneal astigmatism of 0.75D or more in the cataract population. This should result in less spectacle dependence of patients due to the astigmatic correction.

The alternative method to reduce corneal astigmatism as part of cataract surgery is to make incisions on the steeper axis of the cornea such as limbal relaxing incisions or an additional clear corneal incision opposite (OCCI) to the main cataract opening. These techniques are in use since more than 2 decades and are widely used in clinical routine. As with toric IOLs, precise alignment of the cuts with the axis of astigmatism is essential. The disadvantage of the incisional techniques is the variability of the effect between patients since it depends on factors such as the extent of scaring of the cuts after surgery as well as corneal thickness. The main advantage is the simplicity of the technique and the lower cost.

Aim of this study is to compare toric IOL implantation and opposite clear corneal incision during cataract surgery to correct corneal astigmatism.

Condition or Disease Intervention/Treatment Phase
  • Device: toric IOL
  • Procedure: IOL combined with opposite clear corneal incision (OCCI)
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
55 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Comparison of Toric IOL Implantation and Opposite Clear Corneal Incision During Cataract Surgery to Correct Corneal Astigmatism
Study Start Date :
Sep 1, 2010
Actual Primary Completion Date :
Aug 1, 2012
Actual Study Completion Date :
Dec 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: toric IOL

aspherical, toric acrylic IOL (Lentis L-312T, Oculentis, Germany)

Device: toric IOL
implantation of an aspheric, toric, acrylic IOL during cataract surgery

Active Comparator: IOL combined with opposite clear corneal incision (OCCI)

aspherical, acrylic IOL with OCCI

Procedure: IOL combined with opposite clear corneal incision (OCCI)
aspherical, acrylic IOL with opposite clear corneal incision during cataract surgery

Outcome Measures

Primary Outcome Measures

  1. Postoperative residual astigmatism [9 months post-operatively]

Secondary Outcome Measures

  1. uncorrected distance visual acuity (UDVA) [9 months post-operatively]

Other Outcome Measures

  1. postoperative IOL rotation [3 months and 9 months post-operatively]

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Cataract

  • Age 21 and older

  • Regular corneal astigmatism 1.0 up to 2.5 D

  • written informed consent prior to surgery

Exclusion Criteria:
  • Relevant other ophthalmic diseases such as: pseudoexfoliation, glaucoma, traumatic cataract corneal scars, and other co-morbidity that could affect capsule bag stability ( e.g. Marfan syndrome)

  • Irregular corneal astigmatism on corneal topography

Contacts and Locations

Locations

Site City State Country Postal Code
1 Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna Austria 1140

Sponsors and Collaborators

  • Vienna Institute for Research in Ocular Surgery

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Prim. Prof. Dr. Oliver Findl, MBA, MD, MBA, Vienna Institute for Research in Ocular Surgery
ClinicalTrials.gov Identifier:
NCT01763151
Other Study ID Numbers:
  • Viros_Askin
First Posted:
Jan 8, 2013
Last Update Posted:
Jan 10, 2013
Last Verified:
Jan 1, 2013
Keywords provided by Prim. Prof. Dr. Oliver Findl, MBA, MD, MBA, Vienna Institute for Research in Ocular Surgery
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 10, 2013